← FDA Drug Approvals (Drugs@FDA)

OLUX

NDA · New Drug Application · Sponsor: PHARMOBEDIENT · Approved 2000-05-26

Drug application

FDA Application #

NDA021142

Application type

New Drug Application

Brand name

OLUX

Generic name

Clobetasol Propionate

Active ingredients

CLOBETASOL PROPIONATE

Dosage form

AEROSOL, FOAM

Route

TOPICAL

Marketing status

Discontinued

Sponsor

PHARMOBEDIENT

First approval

2000-05-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown